{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:16:25Z","timestamp":1775495785634,"version":"3.50.1"},"reference-count":33,"publisher":"Academy of Managed Care Pharmacy","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.18553\/jmcp.2026.32.4.413","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:29:08Z","timestamp":1774528148000},"page":"413-421","source":"Crossref","is-referenced-by-count":0,"title":["Economic evaluation of ponatinib vs reference and generic imatinib in front-line management of philadelphia chromosome\u2013positive acute lymphoblastic leukemia: A value dilemma"],"prefix":"10.18553","volume":"32","author":[{"given":"Rosemond Sussana","family":"Amamoo","sequence":"first","affiliation":[{"name":"Center for Health Outcomes and Pharmacoeconomic Research, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brielle","family":"Schuerman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mavis","family":"Obeng-Kusi","sequence":"additional","affiliation":[{"name":"Medicine Usage in South Africa (MUSA), North-West University, Potchefstroom, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongseok","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Erstad","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes and Pharmacoeconomic Research, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona"},{"name":"Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Abraham","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes and Pharmacoeconomic Research, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona"},{"name":"Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"r1","unstructured":"Key statistics for acute lymphocytic leukemia (ALL) . Accessed March 16, 2025. https:\/\/www.cancer.org\/cancer\/types\/acute-lymphocytic-leukemia\/about\/key-statistics.html"},{"key":"r2","unstructured":"Acute lymphoblastic leukemia (ALL) treatment | Blood Cancer United. Accessed February 17, 2026. https:\/\/bloodcancerunited.org\/blood-cancer\/leukemia\/acute-lymphoblastic-leukemia-all\/treatment"},{"key":"r3","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231156757"},{"key":"r4","unstructured":"Acute lymphoblastic leukemia . National Comprehensive Cancer Network. Accessed March 16, 2025. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1410"},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35773"},{"key":"r6","unstructured":"Targeted therapy drugs for chronic myeloid leukemia . Accessed March 24, 2025. https:\/\/www.cancer.org\/cancer\/types\/chronic-myeloid-leukemia\/treating\/targeted-therapies.html"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.2398"},{"key":"r8","unstructured":"Brand vs generic drug prescriptions share U.S. 2020-2023. Statista. Accessed March 29, 2025. https:\/\/www.statista.com\/statistics\/205042\/proportion-of-brand-to-generic-prescriptions-dispensed"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.4783"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.2007704"},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02273-8"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01308-8"},{"key":"r13","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v070.i08"},{"key":"r14","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09600-7"},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2011.54.3.106"},{"key":"r16","unstructured":"Micromedex Products: Please Login. Accessed February 17, 2026. https:\/\/www.micromedexsolutions.com\/home\/dispatch"},{"key":"r17","unstructured":"Search the physician fee schedule . Centers for Medicare and Medicaid Services. Accessed March 17, 2025. https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search"},{"key":"r18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-167791"},{"key":"r19","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00566"},{"issue":"7","key":"r20","first-page":"366","volume":"10","author":"Broder MS","year":"2017","journal-title":"Am Health Drug Benefits"},{"key":"r21","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02201-6"},{"issue":"1","key":"r22","first-page":"181","volume":"13","author":"Aristides M","year":"2015","journal-title":"Health Qu"},{"key":"r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196007"},{"key":"r24","unstructured":"BLS data viewer . Accessed March 17, 2025. https:\/\/data.bls.gov\/dataViewer\/view\/timeseries\/CUSR0000SAM2"},{"key":"r25","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.2.146"},{"key":"r26","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-021-01407-9"},{"key":"r27","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.2002320"},{"key":"r28","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004194"},{"key":"r29","unstructured":"Freed M , \nBiniek JF , \nDamico A , \nPublished TN  . Medicare advantage in 2024: Enrollment update and key trends. KFF. August 8, 2024. Accessed April 7, 2025. https:\/\/www.kff.org\/medicare\/issue-brief\/medicare-advantage-in-2024-enrollment-update-and-key-trends"},{"key":"r30","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2025.0049"},{"key":"r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106734"},{"key":"r32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196543"},{"key":"r33","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2016.1164677"}],"container-title":["Journal of Managed Care & Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:43:34Z","timestamp":1775490214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2026.32.4.413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.18553\/jmcp.2026.32.4.413"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2026.32.4.413","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}